The Emergence and Epidemiology of Lyme Borreliosis in Europe and North America

Lyme Borreliosis in Europe and North America: Epidemiology and Clinical Practice

Volumn , Issue , 2011, Pages 1-35

  Sood, Sunil K ^a,b   O'Connell, Susan ^c   Weber, Klaus ^d  

^a Northwell Health   (United States)

^b Donald and Barbara Zucker School of Medicine at Hofstra Northwell   (United States)

^c UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

^d NONE   (Germany)

Author keywords

Europe and North America, and Lyme borreliosis epidemiology Lyme disease, and spirochete Borrelia burgdorferi; Lyme borreliosis in North America, temperate climate zone B. burgdorferi in nature in North America, multihost life cycle of I. scapularis; Mammalian toll like receptor 2 TLR2 , key to innate immune recognition of B. burgdorferi lipoprotein antigens components, by phagocytic and antigen presenting cells

Indexed keywords

EID: 84355162557     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470933961.ch1     Document Type: Chapter

References (191)

1. Ackermann R, Gollmer E, Rehse-Kupper B: Progressive Borrelia encephalomyelitis. Chronic manifestation of erythema chronicum migrans disease of the nervous system. Dtsch Med Wochenschr 110:1039-1042; 1985.
2. Afzelius A: Verhandlungen der Dermatologischen Gesellschaft zu Stockholm, 28 Oct 1909. Arch Dermatol Syph 101:404; 1910.
3. Afzelius A: Erythema chronicum migrans. Acta Derm Venereol 2:120-125; 1921.
4. Anon: Lyme disease in Canada. CMAJ 144:177; 1991.
5. Anon: The Vectorborne Human Diseases of Europe: Their Distribution and Burden on Public Health. World Health Organization Regional Office for Europe; 2004.
6. Anon: National Lyme Disease Meeting March 8-9, 2006. Public Health Agency of Canada; 2006.
7. Asbrink E, Hovmark A, Hederstedt B: The spirochetal etiology of acrodermatitis chronica atrophicans Herxheimer. Acta Derm Venereol 64:506-512; 1984.
8. Bacon RM, Kugeler KJ, Mead PS: Surveillance for Lyme disease. United States, 1992-2006. MMWR Surveill Summ 57:1-9; 2008.
9. Bafverstedt B: Uber Lymphadenosis benigna cutis. Acta derm Venereol (Stockh) 24:1-202; 1943.
10. Bammer H, Schenk K: Meningo-Myelo. Radiculitis after a tick bite with erythema. Dtsch Z Nervenheilkd 187:25-34; 1965.
11. Bannwarth A: Chronische lymphocytare Meningitis, entzundliche Polyneuritis und "Rheumatismus." Arch Psychiatr Nervenkr 113:284-376; 1941.
12. Barbour AG: Isolation and cultivation of Lyme disease spirochetes. Yale J Biol Med 57:521-525; 1984.
13. Barthold SW, De Souza MS, Janotka JL, Smith AL, Persing DH: Chronic Lyme borreliosis in the laboratory mouse. Am J Pathol 143:959-971; 1993.
14. Benach JL, Bosler EM, Hanrahan JP, Coleman JL, Habicht GS, Bast TF, Cameron DJ, Ziegler JL, Barbour AG, Burgdorfer W, Edelman R, Kaslow RA: Spirochetes isolated from the blood of two patients with Lyme disease. N Engl J Med 308:740-742; 1983.
15. Bennet L, Halling A, Berglund J: Increased incidence of Lyme borreliosis in southern Sweden following mild winters and during warm, humid summers. Eur J Clin Microbiol Infect Dis 25:426-432; 2006.
16. Berglund J, Eitrem R, Ornstein K, Lindberg A, Ringer A, Elmrud H, Carlsson M, Runehagen A, Svanborg C, Norrby R: An epidemiologic study of Lyme disease in southern Sweden. N Engl J Med 333:1319-1327; 1995.
17. Biberstein H: Lymphozytome. Zentralbl Hautkr 6:70-71; 1923.
18. Binder E, Doepfmer R, Hornstein O: Experimental transmission of chronic erythema migrans from man to man. Hautarzt 6:494-496; 1955.
19. Brown RN, Lane RS, Dennis DT: Geographic distributions of tick-borne diseases and their vectors. In Goodman JL, Dennis DT, Sonenshine DE (eds): Tick-Borne Diseases of Humans. Washington, DC, American Society for Microbiology; 2005.
20. Buchwald A: Ein Fall von diffuser idiopathischer Haut-Artophie. Arch Derm Syphilol 10:553-556; 1883.
21. Burckhardt JL: Zur Frage der Follikel und Keimzentrenbildung in der haut. Frankf Z Pathol 6:352-359; 1911.
22. Burgdorfer W: Discovery of the Lyme disease spirochete and its relation to tick vectors. Yale J Biol Med 57:515-520; 1984.
23. Burgdorfer W: The historical road to the discovery of Borrelia burgdorferi. In Weber K, Burgdorfer WE (eds): Aspects of Lyme Borreliosis. Berlin, Springer; 1993a.
24. Burgdorfer W: How the discovery of Borrelia burgdorferi came about. Clin Dermatol, 11:335-338; 1993b.
25. Burgdorfer W, Barbour AG, Hayes SF, Benach JL, Grunwaldt E, Davis JP: Lyme disease. A tickborne spirochetosis? Science 216:1317-1319; 1982.
26. Burgdorfer W, Barbour AG, Hayes SF, Peter O, Aeschlimann A: Erythema chronicum migrans. A tickborne spirochetosis. Acta Trop 40:79-83; 1983.
27. Burgdorfer W, Lane RS, Barbour AG, Gresbrink RA, Anderson JR: The western black-legged tick, Ixodes pacificus. A vector of Borrelia burgdorferi. Am J Trop Med Hyg 34:925-930; 1985.
28. Cabello FC, Godfrey HP, Newman SA: Hidden in plain sight. Borrelia burgdorferi and the extracellular matrix. Trends Microbiol 15:350-354; 2007.
29. Carlsson SA, Grandlund H, Nyman D, Wahlberg P: IgG seroprevalence of Lyme borreliosis in the population of the Aland Islands in Finland. Scand J Infect Dis, 30:501-503;1998.
30. Casjens S: Borrelia genomes in the year 2000. J Mol Microbiol Biotechnol 2:401-410; 2000.
31. Casjens S, Palmer N, van Vugt R, Huang WM, Stevenson B, Rosa P, Lathigra R, Sutton G, Peterson J, Dodson RJ, Haft D, Hickey E, Gwinn M, White O, Fraser CM: A bacterial genome in flux. The twelve linear and nine circular extrachromosomal DNAs in an infectious isolate of the Lyme disease spirochete Borrelia burgdorferi. Mol Microbiol 35:490-516; 2000.
32. CDC: Lyme disease. United States, 1980. MMWR Morb Mortal Wkly Rep 30:489-482, 497; 1981.
33. CDC: Lyme disease. United States, 1999. MMWR Morb Mortal Wkly Rep 50:181-185; 2001.
34. CDC: Lyme disease. United States, 2003-2005. MMWR Morb Mortal Wkly Rep 56:573-576; 2007.
35. CDC: Lyme disease (Borrelia burgdorferi) 2008 case definition; 2008.
36. CDC: Notice to readers: final 2008 reports of nationally notifiable infectious diseases. MMWR Morb Mortal Wkly Rep 58:856-869; 2009.
37. CDC: http://www.cdc.gov/ncidod/dvbid/lyme/ld_statistics.htm [Accessed January 26, 2011].
38. Christiansen AH, Molbak K: Neuroborreliosis 1994-2004. Statens Serum Institut; 2005.
39. Coburn J, Fischer JR, Leong JM: Solving a sticky problem. New genetic approaches to host cell adhesion by the Lyme disease spirochete. Mol Microbiol 57:1182-1195; 2005.
40. Comstedt P, Bergstrom S, Olsen B, Garpmo U, Marjavaara L, Mejlon H, Barbour AG, Bunikis J: Migratory passerine birds as reservoirs of Lyme borreliosis in Europe. Emerg Infect Dis 12:1087-1095; 2006.
41. Daniel M, Kriz B, Danielova V, Materna J, Rudenko N, Holubova J, Schwarzova L, Golovchenko M: Occurrence of ticks infected by tickborne encephalitis virus and Borrelia genospecies in mountains of the Czech Republic. Euro Surveill 10:E0503311; 2005.
42. Dayan NE, Rubin LG, Di John D, Sood SK: Hypoglycorrhachia in Lyme meningitis. Pediatr Infect Dis J 23:370-371; 2004.
43. De Mik EL, van Pelt W, Doctors-van Leeuwen BD, van der Veen A, Schellekens JF, Borgdorff MW: The geographical distribution of tick bites and erythema migrans in general practice in the Netherlands. Int J Epidemiol 26:451-457; 1997.
44. Dennis DT: Epidemiology, ecology, and prevention of Lyme disease. In Rahn DW, Evans J (eds): Lyme Disease. Philadelphia, American College of Physicians; 1998.
45. Dennis DT: Epidemiology of Lyme borreliosis. In Gray J, Kahl O, Lane RS, Stanek G (eds): Lyme Borreliosis. Biology, Epidemiology and Control. New York, CAB International; 2002.
46. Dennis DT: Rash decisions: Lyme disease, or not? Clin Infect Dis 41:966-968; 2005.
47. Dotevall L, Alestig K, Hanner P, Norkrans G, Hagberg L: The use of doxycycline in nervous system Borrelia burgdorferi infection. 3 53:74-79; 1988.
48. Duray PH: The surgical pathology of human Lyme disease. An enlarging picture. Am J Surg Pathol, 11 Suppl 1, 47-60; 1987.
49. Edlow JA: Bull's Eye. Unraveling the Medical Mystery of Lyme Disease. New Haven, Yale University Press; 2004.
50. Eisen L: The roles of birds, lizards, and rodents as hosts for the western black-legged tick Ixodes pacificus. J Vector Ecol 29:295-308; 2004.
51. Elliott DJ, Eppes SC, Klein JD: Teratogen update. Lyme disease. Teratology 64:276-281; 2001.
52. EpiNorth. http://www.epinorth.org/eway/default.aspx?pid=230&trg=MainArea_5260&MainArea_ 5260=5279:0:15,2937:1:0:0:::0:0 [Accessed May 8, 2010].
53. European Union Concerted Action on Lyme Borreliosis (EUCALB). Prevention and Control. http://meduni09.edis.at/eucalb/cms/index.php?lang=en [Accessed Jan. 22, 2011].
54. Fingerle V, Schulte-Spechtel UC, Ruzic-Sabljic E, Leonhard S, Hofmann H, Weber K, Pfister K, Strle F, Wilske B: Epidemiological aspects and molecular characterization of Borrelia burgdorferi s.l. from southern Germany with special respect to the new species Borrelia spielmanii sp. nov. Int J Med Microbiol 298:279-290; 2008.
55. Fitzner J, Ammon A, Baumann I, TalaskaT, Schonberg A, StobelK, Fingerle V, Wilske B, Petersen L: Risk factors in Lyme borreliosis. A German case-control study. Int J Med Microbiol 291(suppl 33): 220; 2002.
56. Flanagan BP: Erythema chronicum migrans Afzelius in Americans. Arch Dermatol, 86,410-411; 1962.
57. Flisiak R, Prokopowicz D: [Clinical picture of Lyme boreliosis]. Wiad Parazytol 45:143-149; 1999.
58. Fraser CM, Casjens S, Huang WM, Sutton GG, Clayton R, Lathigra R, White O, Ketchum KA, Dodson R, Hickey EK, Gwinn M, Dougherty B, Tomb JF, Fleischmann RD, Richardson D, Peterson J, Kerlavage AR, Quackenbush J, Salzberg S, Hanson M, van Vugt R, Palmer N, Adams MD, Gocayne J, Weidman J, Utterback T, Watthey L, McDonald L, Artiach P, Bowman C, Garland S, Fuji C, Cotton MD, Horst K, Roberts K, Hatch B, Smith HO, Venter JC: Genomic sequence of a Lyme disease spirochaete, Borrelia burgdorferi. Nature 390:580-586; 1997.
59. Garin C, Bujadoux A: Paralysie par les tiques. J Med Lyon 71:765-767; 1922.
60. Gerber MA, Zalneraitis EL:Childhood neurologic disorders and Lyme disease during pregnancy. Pediatr Neurol 11:41-43; 1994.
61. Gerber MA, Shapiro ED, Burke GS, Parcells VJ, Bell GL: Lyme disease in children in southeastern Connecticut. Pediatric Lyme Disease Study Group. N Engl J Med, 335:1270-1274; 1996.
62. Gern L, Humair PF: Ecology of Borrelia burgdorferi sensu lato in Europe. In Gray J, Kahl O, Lane RS, Stanek G (eds): Lyme Borreliosis: Biology, Epidemiology and Control. Wallingford, Oxon, UK, CABI Publishing; 2002.
63. Gern L, Moran Cadenas F, Burri C: Influence of some climatic factors on Ixodes ricinus ticks studied along altitudinal gradients in two geographic regions in Switzerland. 3; 298 (Suppl 1): 55-59; 2008.
64. Ginsberg HS, Buckley PA, Balmforth MG, Zhioua E, Mitra S, Buckley FG: Reservoir competence of native North American birds for the lyme disease spirochete, Borrelia burgdorferi. J Med Entomol 42:445-449; 2005.
65. Gordillo G, Torres J, Solorzano F, Cedillo-Rivera R, Tapia-Conyer R, Munoz O: Serologic evidences suggesting the presence of Borrelia burgdorferi infection in Mexico.Arch Med Res 30:64-68; 1999.
66. Gordillo-Perez G, Torres J, Solorzano-Santos F, De Martino S, Lipsker D, Velazquez E, Ramon G, Onofre M, Jaulhac B: Borrelia burgdorferi infection and cutaneous Lyme disease, Mexico.Emerg Infect Dis 13:1556-1558; 2007.
67. Gotz H: [Acrodermatitis chronica atrophicans Hexheimer as an infectious disease.]. Hautarzt 5:491-504; 1954.
68. Gotz H: Die Acrodermatitis chronica atrophicans Herxheimer als Infektionskrankheit. Hautarzt 6:249-252; 1955.
69. Gray JS, Kahl O, Robertson JN, Daniel M, Estrada-Pena A, Gettinby G, Jaenson TG, Jensen P, Jongejan F, Korenberg E, Kurtenbach K, Zeman P: Lyme borreliosis habitat assessment. Zentralbl Bakteriol 287:211-228; 1998.
70. Gray J, Kahl O, Lane RS, Stanek G: Lyme Borreliosis: Biology, Epidemiology and Control. New York, CAB International; 2002.
71. Guy EC, Bateman DE, Martyn CN, Heckels JE, Lawton NF: Lyme disease. Prevalence and clinical importance of Borrelia burgdorferi specific IgG in forestry workers. Lancet 1:484-486; 1989.
72. Hanincova K, Kurtenbach K, Diuk-Wasser M, Brei B, Fish D: Epidemic spread of Lyme borreliosis. Northeastern United States. Emerg Infect Dis 12:604-611; 2006.
73. Handrahan JP, Benach JL, Coleman JL, Bosler EM, Morse DL, Cameron DJ, Edelman R, Kaslow RA: Incidence and cumulative frequency of endemic Lyme disease in a community. J Infect Dis 150:489-496; 1984.
74. Hauser W: Wahrscheinliche Infektionskrankheiten der Haut. Handbuch Haut-und Geschlechtskrankheiten. Berlin, Springer; 1965.
75. Hazard GW, Leland K, Mathewson HO: Erythema chronicum migrans and "Lyme arthritis." JAMA 236:2392; 1976.
76. Health Protection Agency (HPA): http://www.hpa.org.uk/Topics/InfectiousDiseases/InfectionsAZ/ LymeDisease/ [Accessed Jan. 22, 2011].
77. Hellerström S: Erythema chronicum migrans Afzelii. Acta Derm Venereol (Stockh) 2:315; 1930.
78. Hellerstrom S: Erythema chronicum migrans Afzelius with meningitis. Acta Derm Venereol 31:227-234; 1951.
79. Herxheimer K, Hartmann K: [Uber acrodermatitis chronica atrophicans]. Arch Dermatol Syph 61:57-76; 1902.
80. Hoen AG, Margos G, Bent SJ, Diuk-Wasser MA, Barbour A, Kurtenbach K, Fish D: Phylogeography of Borrelia burgdorferi in the eastern United States reflects multiple independent Lyme disease emergence events. Proc Natl Acad Sci USA 106:15013-15008; 2009.
81. Hofhuis A, van der Giessen JW, Borgsteede FH, Wielinga PR, Notermans DW, van Pelt W: Lyme borreliosis in the Netherlands. Strong increase in GP consultations and hospital admissions in past 10 years. Euro Surveill 11:E0606222; 2006.
82. Hollstrom E: Successful treatment of erythema migrans Afzelius. Acta Derm Venereol 31:235-243; 1951.
83. Hopf HC: [Acrodermatitis chronica atrophicans (Herxheimer) and the nervous system. Analysis of clinical, physiologic, histologic and electromyographic findings]. Monogr Gesamtgeb Neurol Psychiatr 114:1-130; 1966.
84. Horstrup P, Ackermann R: [Tick born meningopolyneuritis (Garin-Bujadoux, Bannwarth) (author's transl)]. Fortschr Neurol Psychiatr Grenzgeb 41:583-606; 1973.
85. Hovmark A, Asbrink E, Olsson I: The spirochetal etiology of lymphadenosis benigna cutis solitaria. Acta Derm Venereol 66:479-484; 1986.
86. Hristea A, Hristescu S, Ciufecu C, Vasile A: Seroprevalence of Borrelia burgdorferi in Romania. Eur J Epidemiol 17:891-896; 2001.
87. Hubalek Z: Epidemiology of Lyme borreliosis. Curr Probl Dermatol 37:31-50; 2009.
88. Huegli D, Hu CM, Humair PF, Wilske B, Gern L: Apodemus species mice are reservoir hosts of Borrelia garinii OspA serotype 4 in Switzerland. J Clin Microbiol 40:4735-4737; 2002.
89. Huppertz HI, Bohme M, Standaert SM, Karch H, Plotkin SA: Incidence of Lyme borreliosis in the Wurzburg region of Germany. Eur J Clin Microbiol Infect Dis 18:697-703; 1999.
90. Institut de veille sanitaire (INVS): La maladie de Lyme: Donnees de reseau du surveillance de la maladie en Alsace Mars 2001-Fev 2003 (2008). http://www.nvs.sante.fr/publications/2005/lyme_alsace/index.html [Accessed May 8, 2010].
91. Institut de veille sanitaire (INVS): Surveillance de la maladie de Lyme - Reseau Alsace, 2001-2003. http://www.invs.sante.fr/surveillance/lyme/reseau_alsace.htm [Accessed Jan. 22, 2011].
92. Johnson BJB: Personal Communication; 2008.
93. Johnson RC, Schmid GP, Hyde FW, Steigerwalt AG, Brenner DJ: Borrelia burgdorferi sp. nov. Etiologic agent of Lyme disease. International Journal of Systematic Bacteriology 34, 496-497; 1984.
94. Junttila J, Peltomaa M, Soini H, Marjamaki M, Viljanen MK: Prevalence of Borrelia burgdorferi in Ixodes ricinus ticks in urban recreational areas of Helsinki. J Clin Microbiol 37:1361-1365; 1999.
95. Kaufmann-Wolf M: [Uber guartige lymphocytare Neubildungen der Scrotalhaut des Kindes]. Arch fur Dermatol Syph (Berlin) 130:425-435; 1921.
96. Kirstein F, Rijpkema S, Molkenboer M, Gray JS: Local variations in the distribution and prevalence of Borrelia burgdorferi sensu lato genomospecies in Ixodes ricinus ticks. Appl Environ Microbiol 63:1102-1106; 1997.
97. Kristoferitsch W: Neurologic manifestations in Lyme borreliosis. Clin Dermatol 11:393-400; 1993.
98. Kurtenbach K, Sewell HS, Ogden NH, Randolph SE, Nuttall PA: Serum complement sensitivity as a key factor in Lyme disease ecology. Infect Immun 66:1248-1251; 1998.
99. Kurtenbach K, Hanincova K, Tsao JI, Margos G, Fish D, Ogden NH: Fundamental processes in the evolutionary ecology of Lyme borreliosis. Nat Rev Microbiol 4:660-669; 2006.
100. Lane RS, Loye JE: Lyme disease in California. Interrelationship of ixodid ticks (Acari), rodents, and Borrelia burgdorferi. J Med Entomol 28:719-725; 1991.
101. Lane RS, Quistad GB: Borreliacidal factor in the blood of the western fence lizard (Sceloporus occidentalis). J Parasitol 84:29-34; 1998.
102. Lastavica CC, Wilson ML, Berardi VP, Spielman A, Deblinger RD: Rapid emergence of a focal epidemic of Lyme disease in coastal Massachusetts. N Engl J Med 320:133-137; 1989.
103. Letrilliart L, Ragon B, Hanslik T, Flahault A: Lyme disease in France. A primary care-based prospective study. Epidemiol Infect 133:935-942; 2005.
104. Linard C, Lamarque P, Heyman P, Ducoffre G, Luyasu V, Tersago K, Vanwambeke SO, Lambin EF: Determinants of the geographic distribution of Puumala virus and Lyme borreliosis infections in Belgium. Int J Health Geogr 6:15; 2007.
105. Lindenmayer JM, Marshall D, Onderdonk AB: Dogs as sentinels for Lyme disease in Massachusetts. Am J Public Health 81:1448-1455; 1991.
106. Lindgren E, Jaenson TGT: Lyme borreliosis in Europe. Influences of climate and climate change, epidemiology, ecology and adaptation measures. Geneva, World Health Organization Regional Office for Europe; 2006.
107. Lipschutz B: Über eine seltene Erythemform (Erythema chronicum migrans). Archiv fur Dermato-logic und Syphilis 118:349-356; 1913.
108. Lipschutz B: Weiterer Beitrag zur Kenntnis des "Erythema chronicum migrans." Arch DermatolSyph 143:365-374; 1923.
109. Logiudice K, Ostfeld RS, Schmidt KA, Keesing F: The ecology of infectious disease. Effects of host diversity and community composition on Lyme disease risk. Proc Natl Acad Sci USA 100:567-571; 2003.
110. Lopes de Carvalho I, Nuncio MS: Laboratory diagnosis of Lyme borreliosis at the Portuguese National Institute of Health (1990-2004). Euro Surveill 11:257-260; 2006.
111. Lunemann JD, Zarmas S, Priem S, Franz J, Zschenderlein R, Aberer E, Klein R, Schouls L, Burmester GR, Krause A: Rapid typing of Borrelia burgdorferi sensu lato species in specimens from patients with different manifestations of Lyme borreliosis. J Clin Microbiol 39:1130-1133; 2001.
112. Mac MJ, Opler PA, Puckett Haecker CE, Doran PD: Northeast: Forest changes. In U.S. Geological Survey (ed): Status and Trends of the Nation's Biological Resources. Vol. 2. Reston, VA, U.S. Department of the Interior; 1998.
113. Maraspin V, Cimperman J, Lotric-Furlan S, Ruzic-Sabljic E, Jurca T, Picken RN, Strle F: Solitary borrelial lymphocytoma in adult patients. Wien Klin Wochenschr 114:515-523; 2002.
114. Margos G, Gatewood AG, Aanensen DM, Hanincova K, Terekhova D, Vollmer SA, Cornet M, Piesman J, Donaghy M, Bormane A, Hurn MA, Feil EJ, Fish D, Casjens S, Wormser GP, Schwartz I, Kurtenbach K: MLST of housekeeping genes captures geographic population structure and suggests a European origin of Borrelia burgdorferi. Proc Natl Acad Sci USA 105:8730-8735; 2008.
115. Margos G, Vollmer SA, Cornet M, Garnier M, Fingerle V, Wilske B, Bormane A, Vitorino L, Collares-Pereira M, Drancourt M, Kurtenbach K: A new Borrelia species defined by multilocus sequence analysis of housekeeping genes. Appl Environ Microbiol 75:5410-5416; 2009.
116. Marshall W F III, Telford S R III, Rys PN, Rutledge BJ, Mathiesen D, Malawista SE, Spielman A, Persing DH: Detection of Borrelia burgdorferiDNA in museum specimens of Peromyscus leucopus. J Infect Dis 170:1027-1032; 1994.
117. Mast WE, Burrows WM: Erythema chronicum migrans and "Lyme arthritis." JAMA 236:2392; 1976a.
118. Mast WE, Burrows WM Jr: Erythema chronicum migrans in the United States. JAMA 236:859-860; 1976b.
119. Masters EJ, Donnell HD: Lyme and/or Lyme-like disease in Missouri. Mo Med 92:346-353; 1995.
120. Mehnert WH, Krause G: Surveillance of Lyme borreliosis in Germany, 2002 and 2003. Euro Surveill 10:83-85; 2005.
121. Mulic R, Antonijevic S, Klismanic Z, Ropac D, Lucev O: Epidemiological characteristics and clinical manifestations of Lyme borreliosis in Croatia. Mil Med 171:1105-1109; 2006.
122. Mygland A, Ljostad U, Fingerle V, Rupprecht T, Schmutzhard E, Steiner I: European Federation of Neurological Societies. EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis. Eur J Neurol 17:8-16; 2010.
123. Nahimana I, Gern L, Peter O, Praz G., Moosmann Y, Francioli P: [Epidemiology of Lyme borreliosis in French-speaking Switzerland]. Schweiz Med Wochenschr 130:1456-1461; 2000.
124. Nygard K, Brantsaeter AB, Mehl R: Disseminated and chronic Lyme borreliosis in Norway, 1995-2004. Euro Surveill 10:235-238; 2005.
125. Ogden NH, Marouf A, Barker IK, Bigras-Poulin M, Lindsay LR, Morshed MG, O'Callaghan CJ, Ramay F, Waltner-Toews D, Charron DF: Climate change and the potential for range expansion of the Lyme disease vector Ixodes scapularis in Canada. Int J Parasitol 36:63-70; 2006.
126. Ogden NH, Lindsay LR, Hanincova K, Barker IK, Bigras-Poulin M, Charron DF, Heagy A, Francis CM, O'Callaghan CJ, Schwartz I, Thompson RA: Role of migratory birds in introduction and range expansion of Ixodes scapularis ticks and of Borrelia burgdorferi and Anaplasma phagocytophilum in Canada. Appl Environ Microbiol 74:1780-1790; 2008a.
127. Ogden NH, Lindsay LR, Morshed M, Sockett PN, Artsob H: The rising challenge of Lyme borreliosis in Canada. Can Commun Dis Rep 34:1-19; 2008b.
128. Paschoud JM: [Lymphocytoma after tick bite]. Dermatologica 108:435-437; 1954.
129. Paschoud JM: [Lymphadenosis benigna cutis as a communicable infectious disease; new viewpoints on its course, histology and therapy]. Hautarzt 8:197-211; 1957.
130. Petersen LR, Sweeney AH, Checko PJ, Magnarelli LA, Mshar PA, Gunn RA, Hadler JL: Epidemi-ological and clinical features of 1,149 persons with Lyme disease identified by laboratory-based surveillance in Connecticut. Yale J Biol Med 62:253-262; 1989.
131. Pfister HW, Preac-Mursic V, Wilske B, Schielke E, Sorgel F, Einhaupl KM: Randomized comparison of ceftriaxone and cefotaxime in Lyme neuroborreliosis. J Infect Dis 163:311-318; 1991.
132. Philipp MT, Johnson BJ: Animal models of Lyme disease: pathogenesis and immunoprophylaxis. Trends Microbiol 2:431-437; 1994.
133. Philipp MT, Masters E, Wormser GP, Hogrefe W, Martin D: Serologic evaluation of patients from Missouri with erythema migrans-like skin lesions with the C6 Lyme test. Clin Vaccine Immunol 13:1170-1171; 2006.
134. Piesman J, Gern L: Lyme borreliosis in Europe and North America. In Bowman AS, Nuttall, PA (eds): Ticks: Biology, Disease, and Control. Cambridge University Press, Cambridge, UK, 2008, pp. 220-252.
135. Purser JE, Norris SJ: Correlation between plasmid content and infectivity in Borrelia burgdorferi. Proc Natl Acad Sci USA 97:13865-13870; 2000.
136. Qiu WG, Bruno JF, McCaig WD, Xu Y, Livey I, Schriefer ME, Luft BJ: Wide distribution of a high-virulence Borrelia burgdorferi clone in Europe and North America. Emerg Infect Dis 14:1097-1104; 2008.
137. Rand PW, Lacombe EH, Dearborn R, Cahill B, Elias S, Lubelczyk CB, Beckett GA, Smith RP Jr: Passive surveillance in Maine, an area emergent for tick-borne diseases. J Med Entomol 44:1118-1129; 2007.
138. Rath PM, Ibershoff B, Mohnhaupt A, Albig J, Eljaschewitsch B, Jurgens D, Horbach I, Fehrenbach FJ: Seroprevalence of Lyme borreliosis in forestry workers from Brandenburg, Germany. Eur J Clin Microbiol Infect Dis 15:372-377; 1996.
139. Reimer B, Erbas B, Lobbichler K, Truckenbrodt R, Gartner-Kothe U, Kapeller N, Hansen M, Fingerle V, Wilske B, von Sonnenberg F: Seroprevalence of Borrelia infection in occupational tick-exposed people in Bavaria (Germany). Int J Med Microbiol 291(suppl 33): 215; 2002.
140. Robertson JN, Gray JS, Macdonald S, Johnson H: Seroprevalence of Borrelia burgdorferi sensu lato infection in blood donors and park rangers in relation to local habitat. Zentralbl Bakteriol 288:293-301; 1998.
141. Rothermel H, Hedges T.R. III, Steere AC: Optic neuropathy in children with Lyme disease. Pediatrics 108:477-481; 2001.
142. Rupprecht TA, Koedel U, Fingerle V, Pfister HW: The pathogenesis of Lyme neuroborreliosis. From infection to inflammation. Mol Med 14:205-212; 2008.
143. Samuels DS, Radolf JD (eds): Borrelia. Molecular Biology, Host Interaction and Pathogenesis. Norfolk, UK, Caister Academic Press; 2010.
144. Santino I, Dastoli F, Sessa R, Del Piano M: Geographical incidence of infection with Borrelia burgdorferi in Europe. Panminerva Med 39:208-214; 1997.
145. Schaltenbrand G: Chronische aseptische Meningitis. Nervenarzt 20:433-442; 1949.
146. Schaltenbrand G: Radikulomyelomeningitis nach Zeckenbiss. Munch Med Wochenschr 104:829-834; 1962.
147. Schlesinger PA, Duray PH, Burke BA, Steere AC, Stillman MT: Maternal-fetal transmission of the Lyme disease spirochete, Borrelia burgdorferi. Ann Intern Med 103:67-68; 1985.
148. Schmid GP: The global distribution of Lyme disease. Yale J Biol Med 57:617-618; 1984.
149. Schrock CG: Lyme disease: additional evidence of widespread distribution. Recognition of a tickborne dermatitis-encephalitis-arthritis syndrome in an area of known ixodes tick distribution. Am J Med 72:700-706; 1982.
150. Scrimenti RJ: Erythema chronicum migrans. Arch Dermatol 102:104-105; 1970.
151. Scrimenti RJ, Scrimenti M: Lyme disease redux: the legacy of Sven Hellerstrom. Wis Med J 92:20-21; 1993.
152. Shi Y, Xu Q, Seemanapalli SV, McShan K, Liang FT: The dbpBA locus of Borrelia burgdorferi is not essential for infection of mice. Infect Immun 74:6509-6512; 2006.
153. Smith R, Takkinen J: Lyme borreliosis. Europe-wide coordinated surveillance and action needed? Euro Surveill 11:E0606221: 2006.
154. Stamouli M, Totos G, Braun HB, Michel G, Gizaris V: Very low seroprevalence of Lyme borreliosis in young Greek males. Eur J Epidemiol 16:495-496; 2000.
155. Stanek G, Strle F: Lyme borreliosis. Lancet 362:1639-1647; 2003.
156. Stanek G, Fingerle V, Hunfeld KP, Jaulhac B, Kaiser R, Krause A, Kristoferitsch W, O'Connell S, Ornstein K, Strle F, Gray J: Lyme borreliosis. Clinical case definitions for diagnosis and management in Europe. Clin Microbiol Infect; 17:69-79; 2011.
157. Stanek G, Wormser GP, Gray J, Strle F: Lyme borreliosis. Lancet 2011 (in press).
158. Steere AC: Lyme disease. A growing threat to urban populations. Proc Natl Acad Sci USA 91:2378-2383; 1994.
159. Steere AC: Lyme borreliosis in 2005, 30 years after initial observations in Lyme Connecticut. Wien Klin Wochenschr 118:625-633; 2006.
160. Steere AC, Malawista SE, Hardin JA, Ruddy S, Askenase W, Andiman WA: Erythema chronicum migrans and Lyme arthritis. The enlarging clinical spectrum. Ann Intern Med 86:685-698; 1977a.
161. Steere AC, Malawista SE, Snydman DR, Shope RE, Andiman WA, Ross MR, Steele FM: Lyme arthritis. An epidemic of oligoarticular arthritis in children and adults in three Connecticut communities. Arthritis Rheum 20:7-17; 1977b.
162. Steere AC, Broderick TF, Malawista SE: Erythema chronicum migrans and Lyme arthritis. Epidemiologic evidence for a tick vector. Am J Epidemiol 108:312-321; 1978.
163. Steere AC, Malawista SE: Cases of Lyme disease in the United States. Locations correlated with distribution of Ixodes dammini. Ann Intern Med 91:730-733; 1979.
164. Steere AC, Malawista SE, Newman JH, Spieler PN, Bartenhagen NH: Antibiotic therapy in Lyme disease. Ann Intern Med 93:1-8; 1980.
165. Steere AC, Grodzicki RL, Kornblatt AN, Craft JE, Barbour AG, Burgdorfer W, Schmid GP, Johnson E, Malawista SE: The spirochetal etiology of Lyme disease. N Engl J Med 308:733-740; 1983.
166. Steere AC, Snydman D, Murray P, Mensch J, Main AJ Jr, Wallis RC, Shope RE, Malawista SE: Historical perspective of Lyme disease. Zentralbl Bakteriol Mikrobiol Hyg [A] 263:3-6; 1986a.
167. Steere AC, Taylor E, Wilson ML, Levine JF, Spielman A: Longitudinal assessment of the clinical and epidemiological features of Lyme disease in a defined population. J Infect Dis 154:295-300; 1986b.
168. Steere AC, Coburn J, Glickstein L: The emergence of Lyme disease. J Clin Invest 113:1093-1101; 2004.
169. Steere AC, Coburn J, Glickstein L: Lyme borreliosis. In Goodman JL, Dennis DT, Sonenshine DE (eds): Tick-Borne Diseases of Humans. Washington, DC, American Society for Microbiology; 2005.
170. Stefancikova A, Pet'ko B, Rozicka I, Salyova N, Ohlasova D: Epidemiological survey of human borreliosis diagnosed in eastern Slovakia. AnnAgric Environ Med 8:171-1715; 2001.
171. Stefanoff P, Rosinska M, Zielinski A: [Epidemiology of tick-borne diseases in Poland]. Przegl Epidemiol, 60(suppl 1):151-159; 2006.
172. Stevenson B, El-Hage N, Hines MA, Miller JC, Babb K: Differential binding of host complement inhibitor factor H by Borrelia burgdorferi Erp surface proteins. A possible mechanism underlying the expansive host range of Lyme disease spirochetes. Infect Immun 70:491-497; 2002.
173. Stiernstedt G, Gustafsson R, Karlsson M, Svenungsson B, Skoldenberg B: Clinical manifestations and diagnosis of neuroborreliosis. Ann NY Acad Sci 539:46-55; 1988.
174. Strle F: Lyme borreliosis in Slovenia. Zentralbl Bakteriol 289:643-652; 1999.
175. Strobino BA, Williams CL, Abid S, Chalson R, Spierling P: Lyme disease and pregnancy outcome. A prospective study of two thousand prenatal patients. Am J Obstet Gynecol 169:367-374; 1993.
176. Strobino B, Abid S, Gewitz M: Maternal Lyme disease and congenital heart disease. A case-control study in an endemic area. Am J Obstet Gynecol 180:711-716; 1999.
177. Svarts N: Penicillinbehandling vid dermatitis atrophicans Herxheimer. Nord Med 32:2783; 1946.
178. Sweitzer SE, Laymon CW: Acrodermatitis Chronica Atrophicans. Arch Derm Syphilol, 31:196-211; 1935.
179. Thomas DR, Salmon RL, Coleman TJ, Morgan-Capner P, Sillis M, Caul EO, Morgan KL, Paiba GA, Bennett M, Ribeiro D, Lloyd G, Kench SM, Meadows D, Softley P, Chalmers RM: Occupational exposure to animals and risk of zoonotic illness in a cohort of farmers, farmworkers, and their families in England. J Agricultural Safety Health 5:373-382; 1999.
180. Thyresson N: The penicillin treatment of acrodermatitis atrophicans chronica (Herxheimer). Acta Derm Venereol 29:572-621; 1949.
181. Tilly K, Rosa PA, Stewart PE: Biology of infection with Borrelia burgdorferi. Infect Dis Clin North Am 22:217-234; 2008.
182. Varela AS, Luttrell MP, Howerth EW, Moore VA, Davidson WR, Stallknecht DE, Little SE: First culture isolation of Borrelia lonestari, putative agent of southern tick-associated rash illness. J Clin Microbiol 42:1163-1169; 2004.
183. Wang G, van Dam AP, Schwartz I, Dankert J: Molecular typing of Borrelia burgdorferi sensu lato. Taxonomic, epidemiological, and clinical implications. Clin Microbiol Rev 12:633-653; 1999.
184. Weber K: [Erythema chronicum migrans meningitis-a bacterial infectious disease? (author's transl))]. MMWMunch Med Wochenschr 116:1993-1998; 1974.
185. Weber K: Remarks on the infectious disease caused by Borrelia burgdorferi. Zentralbl Bakteriol Mikrobiol Hyg [A] 263:206-208; 1986.
186. Weber K, Bratzke HJ, Neubert U, Wilske B, Duray PH: Borrelia burgdorferi in a newborn despite oral penicillin for Lyme borreliosis during pregnancy. Pediatr Infect Dis J 7:286-289; 1988.
187. Weber K, Burgdorfer W: Aspects of Lyme Borreliosis. Berlin, Springer; 1993.
188. Weber K, Pfister HW: History of Lyme borreliosis in Europe. In Weber K, Burgdorfer WE (eds): Aspects of Lyme Borreliosis. Berlin, Springer; 1993.
189. Weber K, Schierz G, Wilske B, Preac-Mursic V: [Lymphocytoma-a borreliosis?] Z Hautkr 60:1585-1598; 1985.
190. White DJ, Chang HG, Benach JL, Bosler EM, Meldrum SC, Means RG, Debbie JG, Birkhead GS, Morse DL: The geographic spread and temporal increase of the Lyme disease epidemic. JAMA 266:1230-1236; 1991.
191. Wormser GP, Masters E, Liveris D, Nowakowski J, Nadelman RB, Holmgren D, Bittker S, Cooper D, Wang G, Schwartz I: Microbiologic evaluation of patients from Missouri with erythema migrans. Clin Infect Dis 40:423-428; 2005.